E. Vancutsem
AuthID: R-00F-CA3
1
TITLE: Survival outcomes among older adults (OA) receiving second-line therapy for metastatic CRC (mCRC): 5,289 patients (pts) from the ARCAD Clinical Trials Program.
AUTHORS: Nadine Jackson McCleary; William S Harmsen; Eric VanCutsem; Alberto F Sobrero; Richard M Goldberg; Josep Tabernero; Matt Seymour; Leonard B Saltz; Bruce J Giantonio; Arnold Dirk; Mace L Rothenberg; Miriam Koopman; Hans Joachim Schmoll; Henry C Pitot; Paulo Marcelo Hoff; Alfredo Falcone; Aimery De Gramont; Qian Shi;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 15
AUTHORS: Nadine Jackson McCleary; William S Harmsen; Eric VanCutsem; Alberto F Sobrero; Richard M Goldberg; Josep Tabernero; Matt Seymour; Leonard B Saltz; Bruce J Giantonio; Arnold Dirk; Mace L Rothenberg; Miriam Koopman; Hans Joachim Schmoll; Henry C Pitot; Paulo Marcelo Hoff; Alfredo Falcone; Aimery De Gramont; Qian Shi;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 15
INDEXED IN: 
WOS
WOS2
TITLE: Final results of a randomised trial comparing 'Tomudex'(R) (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer
AUTHORS: Cunningham, D; Zalcberg, JR; Rath, U; Oliver, I; vanCutsem, E; Svensson, C; Seitz, JF; Harper, P; Kerr, D; PerezManga, G;
PUBLISHED: 1996, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 7, ISSUE: 9
AUTHORS: Cunningham, D; Zalcberg, JR; Rath, U; Oliver, I; vanCutsem, E; Svensson, C; Seitz, JF; Harper, P; Kerr, D; PerezManga, G;
PUBLISHED: 1996, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 7, ISSUE: 9
INDEXED IN: WOS
WOS